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Abstract
cGMP-phosphodiesterases of the PDE6 family are expressed in retinal photoreceptor cells, where they mediate the phototransduction
cascade. A system for expression of PDE6 in vitro is lacking, thus straining progress in understanding the structure–function relation-
ships of the photoreceptor enzyme. Here, we report generation and characterization of bacterially expressed chimeric PDE5/6 catalytic
domains which are highly soluble, catalytically active, and sensitive to inhibition by the PDE6 P subunit. Two Xexible PDE6 loops, H
and M, impart chimeric PDE5/6 catalytic domains with PDE6-like properties. The replacement of the PDE6 H-loop into the PDE5 cata-
lytic domain increases the catalytic rate and the Km value for cGMP hydrolysis, whereas the substitution of the M-loop produces catalytic
PDE domains responsive to P. Multiple PDE6 segments preventing functional expression of the catalytic domain are identiWed, support-
ing the requirement for specialized photoreceptor chaperones to assist PDE6 folding in vivo.
 2005 Elsevier Ltd. All rights reserved.
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Photoreceptor phosphodiesterases (PDEs)1 are the eVec-
tor enzymes in the vertebrate visual transduction cascade.
They belong to the sixth family (PDE6) of eleven families
of PDEs identiWed in mammals (Beavo, 1995; Francis,
Turko, & Corbin, 2001). Upon photoexcitation of rod or
cone photoreceptor cells, the GTP-bound -subunit is
released from the heterotrimeric visual G protein (trans-
ducin) and stimulates PDE6 activity by relieving the inhibi-
tory constraint imposed by two identical inhibitory P
subunits on the enzyme catalytic dimer. Ensuing drop in
intracellular concentration of cGMP leads to a closure of
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doi:10.1016/j.visres.2005.09.015cGMP-gated channels in the plasma membrane and a neu-
ronal response (Arshavsky, Lamb, & Pugh, 2002; Chabre &
Deterre, 1989). Two unique features of PDE6 enable the
enzyme to fulWll the visual transduction tasks. Firstly, a
high-aYnity interaction with the P-subunits blocks
cGMP-hydrolysis in the dark and thus reduces photorecep-
tor cell noise. Secondly, the cGMP- hydrolytic rate of
PDE6 is remarkably high when P is displaced by trans-
ducin- and provides for robust ampliWcation of the signal.
Despite the prominent role of PDE6 in photoreceptor
biology, the structure–function relationships of this enzyme
family are poorly understood. The lack of understanding of
PDE6 at the molecular level can be mainly attributed to the
failure of useful functional expression of the enzyme in var-
ious systems (Piriev, Yamashita, Samuel, & Farber, 1993;
Piriev, Yamashita, Shih, & Farber, 2003; Qin & Baehr,
1994; Qin, Pittler, & Baehr, 1992). The most promising
results were achieved using the baculovirus/sf9 cell system
(Qin & Baehr, 1994). But even with this system, the yields of
functional rod PDE6 catalytic subunits were very low (50–
100g/L). To date, there are no reports describing puriWca-
tion and characterization of stable recombinant PDE6
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characterization of the chimeric enzymes between cGMP-
binding, cGMP-speciWc PDE5 and PDE6 expressed in
insect cells (Granovsky & Artemyev, 2000; Granovsky
et al., 1998). Although PDE5 is not inhibited by P and its
kcat for cGMP hydrolysis is at least 100-fold lower than that
of PDE6, the enzymes are similar in terms of domain orga-
nization. Like PDE5, PDE6 has two N-terminal GAF
domains (termed for their presence in cGMP-regulated
PDE, Anabaena adenylyl cyclases, and the Escherichia coli
protein Fh1A) and the catalytic domain located in the C-
terminal part of the molecule (Aravind & Ponting, 1997;
Beavo, 1995). In addition, PDE5 and PDE6 share a rela-
tively high homology of the catalytic domains, speciWcity
for cGMP relative to cAMP, and sensitivity to common
catalytic-site inhibitors (Cote, 2004). PDE5/6 chimeras have
helped to delineate the P- and noncatalytic cGMP-binding
sites of PDE6 (Muradov, Boyd, & Artemyev, 2004; Mura-
dov, Granovsky, Schey, & Artemyev, 2002). However, the
utility of this approach to further elucidate the catalytic
determinants of PDE6 is limited since the PDE6 catalytic
domain (cdPDE6) does not correctly fold in the context of
PDE5/6 chimeras (Granovsky & Artemyev, 2001).
The original report by Fink, Francis, Beasley, Grimes,
and Corbin (1999) Wrst established expression of an active,
monomeric catalytic domain of PDE5 (cdPDE5) using the
baculovirus system. Recent studies have demonstrated that
the catalytic domain of PDE5 (cdPDE5) can be function-
ally expressed in E. coli with high yields permitting a solu-
tion of its crystal structure (Huai, Liu, Francis, Corbin, &
Ke, 2004; Sung et al., 2003). The atomic structures of
cdPDE5 facilitate the design of constructs for cdPDE6 and/
or chimeric cdPDE5/6, whereas the bacterial expression
system oVers an advantage of rapid generation and screen-
ing of these constructs. In this study, we examined expres-
sion of rod and cone cdPDE6 as well as chimeric PDE5/6
catalytic domains in E. coli. In contrast to poorly soluble
and inactive cdPDE6, several chimeric cdPDE5/6 were
highly soluble, catalytically active, and inhibited by P.
Characterization of these proteins indicates that they are
well suited for future structural studies of the P/PDE6
interaction.
2. Materials and methods
2.1. Materials
[3H]cGMP was a product of Amersham Pharmacia Bio-
tech. All restriction enzymes were purchased from NEB.
AmpliTaq DNA polymerase was a product of Applied Bio-
systems, and Pfu DNA polymerase was a product of Strat-
agene. Polyclonal anti-His6 antibodies were obtained from
Santa Cruz. All other reagents were purchased from Sigma.
Recombinant P was obtained as described previously
(Artemyev, Arshavsky, & Cote, 1998). Synthetic peptide
corresponding to P-63–87 was custom-made by Sigma–
Genosys and puriWed by reverse-phase HPLC.2.2. Cloning of the PDE5, PDE6 and PDE5/6 chimeric 
catalytic domains
All constructs were cloned into the pET15b vector
(Novagen) using NdeI and XhoI sites. cdPDE5 (aa 525–
850) was ampliWed using pFastBacPDE5 as a template
(Granovsky & Artemyev, 2001) with primers containing
NdeI and XhoI sites (primers 1 and 2, Table 1). Sequences
for cdPDE6 (aa 482–816), cdPDE6 (aa 480–814), and
cdPDE6 (aa 480–814) were ampliWed using a bovine reti-
nal cDNA library kindly provided by Dr. W. Baehr (Uni-
versity of Utah) (see Table 1 for primer information).
Chimera C1 (Fig. 2) was generated by a two-step PCR pro-
cedure. The PDE5(525–716) sequence was ampliWed with a
forward primer 1 containing a Nde site and a reverse primer
9 corresponding to PDE5(706–716)/PDE6(671–681).
This PCR product was used as a forward primer in the sec-
ond PCR ampliWcation with a Xho-containing reverse
primer 4 corresponding to PDE6(804–814). The resulting
PCR product was cut with NdeI/XhoI and inserted into the
pET15b vector. Similar procedures were used for the con-
struction of C2 and C3 (Fig. 2). Chimera C4 was obtained
by ligation of two PCR products into the pET15b vector
cut with NdeI and XhoI. The Wrst PCR product coding for
PDE5(525–652) was ampliWed with a 5 primer 1 and a 3
primer 12 corresponding to PDE5(643–652)/PDE6(607–
615). The second PCR product was obtained by amplifying
PDE5(669–850) with a forward primer 13 corresponding to
PDE6(616–622)/PDE5(669–677) and a reverse primer 2.
Approaches similar to those outlined above were used to
construct the remaining chimeras. The sequences of all chi-
meric PDE constructs were veriWed by automated DNA
sequencing at the University of Iowa DNA Core Facility.
2.3. Isolation and puriWcation of chimeric PDE5/6 catalytic 
domains
Plasmids containing chimeric constructs were trans-
formed into BL21-codon plus competent cells (Stratagene).
Single colonies were picked to inoculate LB medium con-
taining ampicillin. The cultures were incubated overnight at
37 °C, diluted to 0.5–1.0 L (1:100) with 2£ TY medium con-
taining ampicillin. At the cell density of ODD 1 at 600 nm
and selected temperature (typically 16 °C), the cultures were
induced with 100M IPTG. After 16–18 h incubation, cells
were pelletted and stored at ¡80 °C or processed immedi-
ately. Cell pellets were resuspended in 20 mM Tris–HCl
buVer (pH 8.0) containing 500 mM NaCl, 20 mM imidazole,
and Complete Mini protease inhibitor cocktail (Roche
Molecular Biochemicals) and then sonicated with six 20-s
pulses using a Xat tip attached to a 550 Sonic Dismembra-
tor (Fisher ScientiWc). Cell lysates were cleared by centrifu-
gation (100,000g, 1 h, 4 °C) and loaded into NiSO4-charged
His-bind resin (Novagen). The bound proteins were eluted
with 20 mM Tris–HCl pH 8.0, 500 mM NaCl, 200 mM
imidazole. Soluble and fuctional chimeras C4, C5, C6,
and C8 were analyzed as His6-tagged proteins. Control
862 H. Muradov et al. / Vision Research 46 (2006) 860–868Table 1
Oligonucleotide primers used for generation of PDE constructs
a Sequence corresponds to a primer numbered in bold.
Construct Primers Primer sequence
cdPDE5 1 GAGAATACATCATATGGAAGAAACCA
GAGAGCTGCAGTCC
2 GACTTCTCGAGTCACTGCTGTTCTGCA
AGAGCCTGCCATTTCTGCC
cdPDE6 3 GAGAATACATCATATGTGTGAAGAAA
AACAGCTTGTCACAATTTTG
4 GACTTCTCGAGTCAATACTCATCAGCT
AGGGATTTCCATTCCACTCT
cdPDE6 5 GAGAATACATCATATGTGCGAGGAAG
AAGAACTGGCTGAGATCCTG
6 GACTTCTCGAGTCAATACTCATCAGCA
AGCGCTTTCCACTCCTTGC
cdPDE6 7 GAGAATACATCATATGTGCGAGGAGG
ACGAGCTGGGGAAAATCC
8 GACTTCTCGAGTCAGTACTCATCGGCC
AAGGCCTTCCACTCC
C1 1, 4, 9a TTTTTGAAACATGGTTCTCTTCTTGAA
ATATAATGCTAGGTCTGTGGCTAAAA
TAGCTTGCTTGAT
C2 2, 3, 10 GTTCAAAAAATTCTCCTCGTCTCTTTA
TGTACAGAGCCAGGTCAGTCGCTATT
ATCGCAACTTCAAAC
C3 2, 3, 11 GCACTGATCAAAATGATGATGCTCCA
TGATTGAAGAGCCGTGAAGCCTTGCT
AGCGGAGATGTG
C4 1, 2, 12 CGGAGATGTGGACTTCATCTGATACA
AGTTATTGACACCACGGTGATCCAGA
TCATG
13 CTAGCAAGGCTTCACGGCTCTTCAATC
ATGGAGCATCATCATTTTGAT
C5 1, 2, 14 GGGTTGTTGCTGCAGCACTGTTCTCTC
CAGATCTCCTTGTTCCCAAAATTCAGT
GGCAACAAGTTCTGCTATC
15 ATTCCTATGATGGACAGAAACAAAAA
AGATGAACTACCTAAACTTCAAGTTG
GATTCATAGATGCC
C6 1, 2, 16 AAAGATGAACTACCTAAACTTCAAGTT
GGATTTATTGACTTTGTCTGTACTCAA
CTGTATGAGGCCTTGACC
C7 1, 2, 17 GGATTTATTGACTTTGTCTGTACTTTT
CTGTATGAGGCCTTGACCCATGTG
C8 1, 14
C9 1, 2, 18 TTCAGTTTCCATTTTTTCACAGGCATC
AACAATTTTTTGAAACATGGTTCGTCT
CTTTATGTACAGTGCTAG
19 GAAGAGGCCATCAAATATGTAACCAT
TGATCCAACCAAAAAAGAGTTGTTTTT
AGCGATGCTG
C10 3, 4, 20 ATTTTTCATTATAAGTTCAAAAAATTC
TCCTCTCTTCTTGAAATATAAAGCCAG
21 CAATTCAATTTGGAAGATCCTCATCA
AAAGGAGATTATCATGGCAATGATG
ATG
C11 2, 3, 20
C12 2, 22 GACTATTAAGGATCATCAGGCAGTAC
TCCAGGTGGTGCCTCTCCAAGATGGA
AGAGCCGTGAAGCCTTGCTAGCGGAG
C13 4, 23 ACAAGGAGATCTGGAGAGAACAGTGC
TGCAGCAAC
C14 1, 4, 24 CGTTAAACCCGTGTCGCCAGTTGTGG
TAGGCGACGTTCTTCCGATAGTTCTTC
TTCACexperiments showed no diVerences in stability, catalytic
properties, or P-inhibition of these chimeras prior to or
after removing the His6-tag with thrombin.
2.4. PDE activity assay
PDE activity was measured using [3H]cGMP as
described (Muradov et al., 2004). BrieXy, 5–20 nM of
cdPDE5/6 were incubated in 80L of 20 mM Tris–HCl (pH
8.0) buVer containing 50 mM NaCl, 10 mM MgSO4, 2 mM
2-mercaptoethanol, 0.1 U bacterial alkaline phosphatase,
0.3 mg/mL BSA, and 5M [3H]cGMP (100,000 cpm) at
25 °C. After addition of [3H]cGMP, the reaction was
allowed to proceed for 10 min and was stopped by the addi-
tion of AG1-X2 cation exchange resin (0.5 mL of 20% bed
volume suspension). Samples were incubated for 10 min at
25 °C with occasional mixing and spun at 9000g for 2 min.
Aliquots of 0.25 mL were removed for counting in a scintil-
lation counter. To determine Km values for cGMP, PDE
activity was measured using 0.5–100M cGMP and the
data were Wt to equation Y D Vmax ¤ X/(Km + X). The kcat
values for cGMP hydrolysis were calculated as Vmax/[PDE].
To determine Ki values for P and P-63–87, PDE activity
was measured with 5M [3H]cGMP in the presence of
increasing concentrations of P or P-63–87. The Ki values
were calculated by Wtting data to equation: Y (%) D 100/
(1 + 10((X ¡ LogKi))), where X is the logarithm of total P
or P-63–87 concentration. Fitting the experimental data to
equations was performed with nonlinear least squares crite-
ria using GraphPad Prizm 4 Software. The Km, Ki, and kcat
values are expressed as means § SE for three independent
experiments.
2.5. Gel Wltration analysis
Aliquots of cdPDE samples (50–100L, »1 mg) were
injected into a Superose 12 10/30 column (Amersham Phar-
macia Biotech) equilibrated at 25 °C with 20 mM Tris–HCl
buVer (pH 8.0) containing 100 mM NaCl, 10 mM MgSO4,
and 2 mM 2-mercaptoethanol. Proteins were eluted at
0.4 mL/min, and 0.4 mL fractions were collected. Each frac-
tion was assayed by SDS–PAGE and for PDE activity.
PDE activity was measured using 10–20L aliquots from
fractions and 5M [3H]cGMP as described above. The col-
umn was calibrated with the following protein standards:
sweet potato -amylase (200 kDa), bovine serum albumin
(67 kDa), chicken ovalbumin (45 kDa), and bovine erythro-
cyte carbonic anhydrase (29 kDa).
2.6. Native gel electrophoresis
Native gel electrophoresis of cdPDE was run in precast
7.5% acrylamide gels (Bio-Rad) according to the manufac-
ture’s protocol. Samples of cdPDE were diluted with two
volumes of sample buVer (62.5 mM Tris–HCl, pH 6.8, 40%
glycerol, and 0.01% bromophenol blue), loaded on an acryl-
amide gel, and run at 25 °C with constant voltage of 180 V
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glycine (pH 8.3) was used as electrode buVer.
2.7. Other methods
Western blot analysis of proteins was performed follow-
ing SDS–PAGE in 10% gels. Chimeric cdPDE5/6 were
detected using anti-His6 polyclonal antibodies (Santa Cruz)
(dilution 1:3000), anti-rabbit antibodies conjugated to horse-
radish peroxidase (Sigma), and ECL reagents (Amersham
Biosciences). The immunoblot analysis following native gel
electrophoresis was performed using anti-P-63–87 antibod-
ies (gift of Dr. R. Cote, University of New Hampshire). Pro-
tein concentrations were determined by the method of
Bradford (1976) using IgG as a standard. Molar concentra-
tions of cdPDE5/6 were calculated based on the MW values
calculated from the sequences of individual constructs.
3. Results
3.1. Expression of the PDE5 and PDE6 catalytic domains in 
E. coli
The sequence for the construct of bovine cdPDE5 (aa
525–850) (cdPDE5) was chosen to correspond exactly tothe human cdPDE5 previously expressed in E. coli and
crystallized (Huai et al., 2004; Sung et al., 2003). Sequences
for expression of the bovine cone cdPDE6 (aa 480–814),
rod cdPDE6 (aa 482–816), and cdPDE6 (aa 480–814)
were selected based on the alignment with cdPDE5 (Figs. 1
and 2). All four cdPDE were expressed in E. coli as His6-
tagged proteins and puriWed on a His-bind resin column. A
typical yield of puriWed cdPDE5 was 5–6 mg/L with the Km
value of 6.3M and kcat of 1.1 s
¡1. (Fig. 3, Table 2). In con-
trast to cdPDE5, the recombinant cdPDE6, cdPDE6,
and cdPDE6 were found predominantly in insoluble
inclusion bodies after centrifugation of E. coli cell lysates
(100,000g, 1 h). Trace amounts of the PDE6 proteins
detected in the supernatant by Western blotting did not
show enzymatic activity. Abundant formation of inclusion
bodies in the absence of functional PDE6 proteins indi-
cated misfolding and aggregation of cdPDE6. Subse-
quently, chimeric cdPDE5/6 were designed to localize
sequences preventing functional expression of cdPDE6.
3.2. Expression and characterization of chimeric PDE5/6 
catalytic domains
The crystal structures of the PDE5 catalytic domain
show that it contains 16 helices that fold into three helicalFig. 1. Sequence alignment of the catalytic domains of bovine rod PDE6 (6A and 6B), cone PDE6 (6C), and PDE5 (5A). The borders of the subdomains
S1, S2, S3 (Sung et al., 2003), and the sequences corresponding to the metal-binding sites MI and MII, H-and M-loops, and the -hairpin region are indi-
cated with arrows.
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region (S2), and a C-terminal helical bundle (S3) (Fig. 2)
(Huai et al., 2004; Sung et al., 2003). The connecting
sequence between the second and third subdomains is
highly conserved between PDE5 and PDE6 (Fig. 1).
Accordingly, chimera C1 was planned to include the subdo-
mains 1 and 2 of cdPDE5, and the subdomain 3 from
Fig. 3. Expression of the chimeric PDE5/6 catalytic domains in E. coli. A
coomassie blue-stained SDS-gel with the puriWed cdPDE5 and catalyti-
cally active chimeras C4, C5, C6, and C8. Equal fractions (0.3%) of the
cdPDE preparations isolated from 1 L cultures were loaded into the gel to
illustrate the expression yields of individual chimeras (15 g cdPDE5,
33 g C4, 18 g C5, 24 g C6, and 30 g C8). Arrows indicate correspond-
ing Precision Plus Protein™ standards (Bio-Rad).
cdPDE5  C4    C5      C6    C8
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37
50
kDa PDE6, while C2 was reciprocal to C1 (Figs. 1 and 2).
Both, C1 and C2 were catalytically inactive and formed
inclusion bodies, suggesting that either each of the portions
of cdPDE6 contains a misfolded sequence, or essential
intramolecular contacts were missing in the chimeric
domains. Chimera C3 containing the subdomain 1 of
PDE was generated next (Fig. 2). This chimeric protein
was also insoluble and inactive (not shown).
In a modiWed approach to PDE5/6 chimera design, we
identiWed three regions that are likely to adopt diVerent
conformations in cdPDE5 and cdPDE6. Two such regions
are counterparts of the H- and M-loops in the crystal struc-
ture of human PDE5 (Huai et al., 2004) (Fig. 2). The H- and
M-loops adopt very diVerent conformations in otherwise
well-superimposable structures of cdPDE5A and cdPDE4D
(Xu et al., 2000). Furthermore, these loops display confor-
mational diVerences in the IBMX- and sildenaWl-bound
structures of cdPDE5 (Huai et al., 2004; Sung et al., 2003).
The H-loop and M-loop of PDE5 were substituted by the
equivalent PDE6 sequences in chimeras C4 and C5,
respectively (Fig. 2). The H-loop is comprised of residues
651–666 of bovine PDE5 (Huai et al., 2004). The replacedFig. 2. Schematic representation of PDE5/6 chimeric catalytic domains. Asterisks denote catalytically active chimeric PDE constructs.
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idues corresponding to positions 651 and 652 are identical
in PDE5 and PDE6. Two extra residues, 667 and 668,
were added to the replaced sequence to join the PDE6/
PDE5 sequences at conserved residues (Fig. 1). The PDE5
sequence 777–806 substituted in C5 was extended by 4
residues from the M-loop sequence 777–802 (Huai et al.,
2004) to also provide for the junction with conserved resi-
dues. Chimeras C4 and C5 were expressed as soluble and
catalytically active proteins. On SDS–PAGE C4 and C5
migrated similarly to cdPDE5 with an apparent MW of
»33 kDa, which is somewhat lower than the MW values
calculated from their sequences (Fig. 3, Table 2). Interest-
ingly, the level of expression and yield of puriWed C4 (10–
12 mg/L) exceeded those for cdPDE5 and C5 (5–7 mg/L)
(Fig. 3, Table 2). In addition, C4 displayed »2.5-fold
increases in the Km and kcat values for cGMP hydrolysis
(Table 2), which represents a shift toward a more PDE6-
like enzyme. In contrast, chimera C5 had a reduced kcat of
0.36 s¡1, whereas the Km value was modestly lower in com-
parison to cdPDE5 (Table 2).
The M-loop comprises a portion of the PDE6-737–
784 sequence, which has been previously shown to impart
P-inhibition on the PDE5/PDE6 chimeric enzyme (Gra-
novsky & Artemyev, 2000). The analysis of the C4 and C5
inhibition by P indicated that C5, unlike C4 and the
PDE5 catalytic domain, is sensitive to P (Fig. 4). Resi-
dues Phe777 and Phe781 of PDE6 located C-terminally tothe M-loop have been earlier implicated in the interaction
with P (Granovsky & Artemyev, 2001). To probe the role
of these residues in context of the chimeric catalytic
domain, two extensions of the PDE6 sequence, consisting
of 10-residues and 11-residues each, were made to the M-
loop in C6 and C7, respectively (Fig. 2). C6 was similar to
C5 in terms of catalytic properties, but its inhibition by P
was signiWcantly more potent, thus supporting the
involvement of Phe777 and the surrounding residues in the
interface with the inhibitory subunit (Table 2, Fig. 4A).
Surprisingly, addition of a single residue Phe781 led to
expression of insoluble inactive chimera C7 (not shown).
The ability of the P C-terminal peptide, P-63–87, to
inhibit C5 and C6 was also tested. The peptide Ki values
for the inhibition of C5 and C6 were 18.5 and 1.7 M,
respectively, reXecting the stronger interaction of P-63–
87 with C6 (Fig. 4B, Table 2).
Based on the functionality of C4 and C5, chimera C8
combining the H- and M-loops from PDE6 has been con-
structed and examined. Similarly to C4, C8 exhibited
increased expression levels and elevated Km and kcat values
(Fig. 3, Table 2). Like C5, C8 was inhibited by P. Unex-
pectedly, the presence of the H-loop from PDE6 in C8
reduced the eVectiveness of P inhibition (Table 2).
In addition to the H- and M-loops, a third region cor-
responding to the loop between helices 12 and 13 is pre-
dicted to be conformationally dissimilar in PDE5 and
PDE6. This loop is relatively short in PDE5, but extendedTable 2
Properties of cdPDE5 and chimeric PDE5/6 catalytic domains
NA – no inhibition of PDE activity was detected when using up to 0.5 mM P or P-63–87.
a Including the His-tag.
b Means § SE (n D 3).
c Data for the full-length native PDE6 from Gillespie and Beavo (1988) and Granovsky et al. (1998).
Construct Calculated MW (kDa)a Yield (mg/L) Km for cGMP (M)
b kcat (s
¡1)b Ki for P (M)
b Ki for P-63–87 (M)
b
cdPDE5 39.99 5–6 6.3 § 0.8 1.1 § 0.2 NA NA
C4 39.84 10–12 15.8 § 2.2 2.4 § 0.3 NA NA
C5 40.03 5–7 3.8 § 0.7 0.36 § 0.05 19.6 § 2.0 18.5 § 3.6
C6 40.07 7–8 2.5 § 0.2 0.35 § 0.04 2.7 § 0.2 1.7 § 0.2
C8 39.83 9–10 15.2 § 1.6 2.2 § 0.1 95 § 15
PDE6c 17–23 1200–3500 0.00017Fig. 4. Inhibition of chimeras C5 and C6 by P and P-63–87. The activities of C5 and C6 were measured in the presence of 5 M cGMP and increasing
concentrations of P (A) or P-63–87 (B) and are expressed as a percentage of the respective PDE activity in the absence of P. Results of representative
experiments are shown. The Ki values are shown in Table 2 as means § SE from three separate experiments.
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hairpin region is even longer in PDE6 (Fig. 1). The diVer-
ence in the lengths of the hairpin regions represents one of
the most obvious distinctions between PDE5 and PDE6.
The loop H12–H13 of PDE5 was replaced by the -hair-
pin region of PDE6 in C9. This replacement produced
insoluble and inactive catalytic domain, indicating that
the PDE6 hairpin loop alone may impede correct folding
of recombinant PDE6. This possibility was tested by
making the PDE6 catalytic domain in which the hairpin
sequence was substituted by the corresponding loop of
PDE5 (C10) (Fig. 2). Chimera C10 too yielded inactive
protein found largely in inclusion bodies.
To further delineate regions causing misfolding and
aggregation of recombinant cdPDE6, several new chime-
ras were designed using the template of C8. The PDE6
H-loop sequence was extended C-terminally to include
the full subdomain S2 of PDE6(C11) or just the adja-
cent 10 residues (C12). In C13, the C-terminus of the
PDE6 catalytic domain was added to the M-loop
sequence (Fig. 2). Expression of C11, C12, and C13 did
not produce functional proteins. Furthermore, the N-ter-
minal addition to the H-loop of the PDE6 region with
metal-binding sites I and II also resulted in inactive and
insoluble chimera C14 (Fig. 2).
3.3. Analyses of the P-binding chimera C6 by gel Wltration 
and native gel electrophoresis
The ability of P or the P C-terminal peptide to
potently inhibit C6 indicated that this chimeric cdPDE
may potentially be a useful tool for structural studies of
the P/PDE6 interaction. Therefore, C6 was further ana-
lyzed by gel Wltration and native gel SDS–PAGE. The
proWles of protein and PDE activity elution from a cali-
brated Superose 12 10/30 column showed a single peak
corresponding to monomeric C6 with apparent MW of
»36 kDa (Fig. 5). The elution proWle of cdPDE5 was very
similar to that of C5 (not shown), consistent with the pre-
vious characterization of cdPDE5 as a monomer (Fink
et al., 1999).
In addition to providing information on protein oligo-
merization/aggregation state, native gel electrophoresis
often allows the characterization of protein–protein inter-
actions. The P-interacting chimeras C5 and C6 migrated
on the native gel similar to cdPDE5 as single bands with
no detectable protein aggregation. Addition of P-63–87
had no eVect on the migration of cdPDE5, but has
resulted in appearance of faster migrating species of C5
and C6 (Fig. 6A). P-63–87 is acidic (pI »4.4) and the
shift is consistent with the peptide/chimera complex. The
immunoblot analysis of the native gel conWrmed that the
shifted C5 and C6 bands contain bound P-63–87 while
no peptide co-migrated with cdPDE5 (Fig. 6B). In agree-
ment with a stronger interaction of C6 with P-63–87, the
amount of peptide bound to C6 was greater than to C5
(Fig. 6B).4. Discussion
Recent advances in bacterial expression and structural
analysis of the PDE1, PDE4, and PDE5 catalytic domains
have generated the impetus to apply a similar approach to
analysis of cdPDE6 (Huai et al., 2004; Sung et al., 2003; Xu
et al., 2000; Zhang et al., 2004). Previous studies have estab-
lished that misfolding of cdPDE6 is a primary reason for
the failed attempts of functional expression of the photore-
ceptor enzymes (Granovsky et al., 1998). Our experiments
using the bovine cdPDE5 construct have conWrmed its
excellent expression in E. coli at an optimal low tempera-
ture of 16 °C. However, attempts to express rod and cone
Fig. 5. Analysis of chimera C6 by gel Wltration. A sample of C6 (100 L,
10 mg/mL) was injected on the Superose 12 10/30 column. Fractions of
0.4 mL were collected and then analyzed for PDE activity () and by
SDS–PAGE. The gel was stained with coomassie blue. The column was
calibrated with the following protein standards: sweet potato -amylase
(200 kDa), bovine serum albumin (67 kDa), chicken ovalbumin (45 kDa),
and bovine erythrocyte carbonic anhydrase (29 kDa).
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Fig. 6. Analysis of the P-interacting chimeras C5 and C6 by native gel elec-
trophoresis. Samples of cdPDE5, C5, and C6 (30 M each) alone or preincu-
bated for 15 min at 25 °C with P-63–87 (100M) were run in native 7.5%
acrylamide gels (15g cdPDE per lane for coomassie blue staining, 1 g for
immunoblotting). The gels were stained with coomassie blue (A) or ana-
lyzed by immunoblotting with anti-P-63–87 antibodies (B).
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cdPDE5, at temperatures ranging from 12 to 37 °C pro-
duced no soluble or active PDE6 proteins. Subsequently,
extensive analysis of chimeric cdPDE5/6 revealed two
important PDE6 regions allowing production of the active
enzyme and at least four regions preventing functional
PDE6 folding.
The Wrst permissible region corresponds to the Xexible
H-loop of PDE6 within the C-terminal region of the S1-
subdomain. The eVect of incorporation of the PDE6 H-
loop was 2-fold: (a) an augmented expression of the active
catalytic domain, and (b) an increase in the kcat and Km val-
ues for cGMP-hydrolysis. Although, the N-terminal addi-
tion of the PDE6 metal-binding sites MI and MII to the
H-loop resulted in inactive protein in the context of chi-
mera C14, the replacement of the PDE6 segment Xanked by
MI and MII into the full-length PDE5 had been shown to
produce a functional PDE chimeric enzyme Chi20 in sf9
cells (Granovsky & Artemyev, 2001). Notably, Chi20 also
displayed a higher catalytic rate. Thus, the results of this
study combined with previous Wndings suggest that the C-
half of the S1-subdomain comprising the metal-binding
sites and the H-loop plays an essential role in determining
the catalytic properties of PDE6.
The second permissible PDE6 region corresponds to the
extended M-loop within the S3 subdomain. The replace-
ment of this region in cdPDE5 by the PDE6 sequence
produced the chimeric domain C6, which was eVectively
inhibited by P. Supporting existing evidence on the inter-
action of cdPDE6 with the C-terminus of P (Granovsky,
Natochin, & Artemyev, 1997), P-63–87 inhibited C6 as
potently as the full-length P. Furthermore, the peptide Ki
values for C6 (1.7M) and trypsin-activated PDE6 from
bovine retina (0.8M) (Skiba, Artemyev, & Hamm, 1995)
are comparable, indicating that most of the contacts
between cdPDE6 and the P C-terminus are recaptured in
C6. Gel-Wltration and native gel PAGE analyses indicate
that C6 is a monomeric protein well-suited for structural
studies of the P/PDE6 interaction.
The regions found to interfere with a functional fold of
cdPDE6 include the N-terminal part of the S1-subdomain,
the S2-subdomain, and the -hairpin loop, and the C-termi-
nus of the S3-subdomain. In general, these regions are least
conserved between cdPDE5 and cdPDE6. The multiplicity
and extensive nature of the misfolding segments support
the requirement of speciWc chaperones for functional
expression of PDE6. Recently, the aryl hydrocarbon recep-
tor-interacting protein-like 1 (AIPL1) was shown to be a
specialized chaperone obligatory for expression and stabil-
ity of PDE6 in rod photoreceptors (Liu et al., 2004; Rama-
murthy, Niemi, Reh, & Hurley, 2004). Mutations in AIPL1
cause Leber’s congenital amaurosis (LCA), a severe form of
retinal dystrophy in humans, apparently by compromising
PDE6 expression (Sohocki et al., 2000). Co-expression of
cdPDE6 with AIPL1 in E. coli produced inactive protein
(Muradov and Artemyev, unpublished). It is very likely
that the isoprenoid modiWcations of the PDE6 C-terminiplay a signiWcant role in PDE6 folding and stability. Substi-
tutions of the Cys-residues in the CAAX box of PDE6
and PDE6 abolished posttranslational isoprenylation and
substantially reduced the protein expression level (Qin &
Baehr, 1994). Furthermore, the PDE6 isoprenylation, and
particularly, farnesylation of PDE6, may be essential to
the ability of AIPL1 to serve as the enzyme chaperone
(Ramamurthy et al., 2003). Recombinant cdPDE6 is not
isoprenylated, which may explain the lack of AIPL1 eVect.
Yet, additional PDE6 chaperones are likely to exist. Co-
expression of isoprenylated PDE6 with AIPL1 in COS cells
also failed to yield a functional enzyme (Liu et al., 2004).
Therefore, a successful strategy to functional expression of
PDE6 most certainly will include identiWcation of new pho-
toreceptor-speciWc factors assisting PDE6 folding.
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